Fundz

Fundz Deep Dive

Everything you need to win Laurence De Moerlooze — in one platform.

Who to reach, what to say, and why now on Laurence De Moerlooze — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Laurence De Moerlooze — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

P95 Appoints Laurence De Moerlooze As Chief Medical Officer

PRIVATEJul 17, 2024almost 2 years ago

Position

Chief Medical Officer

Company

P95

Laurence De Moerlooze
LeuvenBiotechnologyHealth Care

Description

P95 has appointed Laurence De Moerlooze as Chief Medical Officer. Laurence will provide medical leadership and spearhead operational oversight across P95's clinical and epidemiology activities, driving forward the company's strategic goals in vaccine innovation and public health.

Company Information

Company

P95

Location

Leuven, Flemish Brabant, Belgium

About

P95 is a leading global provider of epidemiology and clinical solutions with a specialty focus on vaccines and infectious diseases. The company has regional hub offices in Africa, Latin America, North America, and Southeast Asia. P95 offers high-quality services including clinical trials, epidemiology, and real-world evidence. With a team of 300 professionals across 30 countries, it supports various clients, from pharmaceutical companies to public health institutions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for P95's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.